Huperzine A for Alzheimer's disease. [Cochrane Database Syst Rev. 2008] - PubMed - NCBI - 0 views
-
Nathan Goodyear on 03 Oct 12Review of 6 trials on 454 patients found Huperzine A improved cognition and executive function with no serious adverse events in patients with Alzheimer's disease. Yet, their conclusion is, "...inadequate evidence to make any recommendation..." Does it improve executive cognitive function? Yes. Does in have serious side effects? No. And we are waiting on...?